SearchAs the world's second-largest biopharma market, China offers huge market potential. For EBP companies wanting to create development programs that lead to market access in China, IQB China is your trusted partner for EBP clinical trial development and market entry.
China - One of the fastest growing countries for biopharma
Oct 26, 2021
You may also be interested in